Abstract
Revised guidelines for the prevention of infective endocarditis published by the American Heart Association in 2007 do not support the indiscriminate use of antibiotic prophylaxis for dental procedures. However, they still recommend the use of prophylaxis for high-risk patients before dental treatments likely to cause bleeding. Given the high prevalence of bacteremia of dental origin due to tooth-brushing, mastication or other daily activities, it appears unlikely that infective endocarditis from oral microorganisms can be completely prevented. A good oral health status and satisfactory level of oral hygiene are sufficient to control the consequences of the systemic spread of oral microorganisms in healthy individuals. However, caution is still needed and prophylactic antibiotics must be administered to susceptible or medically compromised patients. This review briefly outlines the current concepts of odontogenic bacteraemia and antibiotic prophylaxis for patients undergoing dental treatment.
Cardiovascular & Hematological Disorders-Drug Targets
Title: Odontogenic Infections in the Etiology of Infective Endocarditis
Volume: 9 Issue: 4
Author(s): Antonio Bascones-Martinez, Marta Munoz-Corcuera and Jukka H. Meurman
Affiliation:
Abstract: Revised guidelines for the prevention of infective endocarditis published by the American Heart Association in 2007 do not support the indiscriminate use of antibiotic prophylaxis for dental procedures. However, they still recommend the use of prophylaxis for high-risk patients before dental treatments likely to cause bleeding. Given the high prevalence of bacteremia of dental origin due to tooth-brushing, mastication or other daily activities, it appears unlikely that infective endocarditis from oral microorganisms can be completely prevented. A good oral health status and satisfactory level of oral hygiene are sufficient to control the consequences of the systemic spread of oral microorganisms in healthy individuals. However, caution is still needed and prophylactic antibiotics must be administered to susceptible or medically compromised patients. This review briefly outlines the current concepts of odontogenic bacteraemia and antibiotic prophylaxis for patients undergoing dental treatment.
Export Options
About this article
Cite this article as:
Bascones-Martinez Antonio, Munoz-Corcuera Marta and Meurman H. Jukka, Odontogenic Infections in the Etiology of Infective Endocarditis, Cardiovascular & Hematological Disorders-Drug Targets 2009; 9 (4) . https://dx.doi.org/10.2174/1871529X10909040231
DOI https://dx.doi.org/10.2174/1871529X10909040231 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Therapeutic Agents for Resistant Gram-Positive Infections
Current Drug Therapy Long-term Results After Transcatheter Aortic Valve Implantation: What do we Know Today?
Current Cardiology Reviews Small Molecule Inhibitors Limit Endothelial Cell Invasion by Staphylococcus aureus
Current Pharmaceutical Biotechnology Topical Antimicrobials for Burn Wound Infections
Recent Patents on Anti-Infective Drug Discovery Immunopathological Aspects of Mycoplasma pneumoniae Infection
Current Pediatric Reviews Prevention of Cardiovascular Complications in the Marfan Syndrome
Vascular Disease Prevention (Discontinued) Cardiovascular Disease in Antiphospholipid Syndrome
Current Vascular Pharmacology Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise
Current Psychopharmacology Molecular Imaging of Apoptosis In Vivo with Scintigraphic and Optical Biomarkers – A Status Report
Anti-Cancer Agents in Medicinal Chemistry Novel Approaches to Control Biofilm Infections
Current Medicinal Chemistry Chromogranin A-Derived Peptides Are Involved in Innate Immunity
Current Medicinal Chemistry Ethanol and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Review of Macrolide Treatment of Atherosclerosis and Abdominal Aortic Aneurysms
Current Drug Targets - Infectious Disorders Vasopressin and Terlipressin in Neonates and Children with Refractory Septic Shock
Current Drug Metabolism Effectiveness of Antiviral and Immunomodulatory Agents in the Treatment of COVID-19: A Systematic Review
Current Respiratory Medicine Reviews Activation of Macrophages: Establishing a Role for Polysaccharides in Drug Delivery Strategies Envisaging Antibacterial Therapy
Current Pharmaceutical Design Antimicrobial Peptides as Anti-biofilm Agents in Medical Implants
Current Topics in Medicinal Chemistry <i>Corynebacterium Striatum</i>, an Emerging Nosocomial Pathogen: Case Reports
Infectious Disorders - Drug Targets Synthesis, Structure and Antibacterial Evaluation of Some N-substituted 3-amino-5-hydroxy-4-phenyl-1H-pyrazole-1-carboxamides
Medicinal Chemistry New Perspectives of Infections in Cardiovascular Disease
Current Cardiology Reviews